Andrew Hughes
Directeur/Bestuurslid bij CellCentric Ltd.
Profiel
Andrew Hughes is currently a Non-Executive Director at CellCentric Ltd.
and a Strategy Director at Manchester Cancer Research Centre.
Previously, he worked as the Chairman of Translational Medicine at The University of Manchester, an Independent Director at PCI Biotech Holding ASA, and the Worldwide Clinical Head of Early Phase Oncology at AstraZeneca AS.
Actieve functies van Andrew Hughes
| Bedrijven | Functie | Begin |
|---|---|---|
| Manchester Cancer Research Centre | Corporate Officer/Principal | - |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 06-04-2022 |
Eerdere bekende functies van Andrew Hughes
| Bedrijven | Functie | Einde |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Directeur/Bestuurslid | 25-05-2023 |
| The University of Manchester | Corporate Officer/Principal | - |
| AstraZeneca AS | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| AstraZeneca AS | |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Manchester Cancer Research Centre |
